Main > DERMATOLOGY > Psoriasis>Plaque Psoriasis (**) > Treatment > Co: BE. U. CertolizuMAb Pegol **

---

Co: BE. U. CertolizuMAb Pegol **'s subsections
(*) CA Approval Date: 2019. 03.25.
(*) USA Approval Date: 2018. 05.28.
Company
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 4
Patent>UpDate: 2019. 03.19.
TradeMark
TradeMark Web-Site

Co: BE. U. CertolizuMAb Pegol **'s products
This section has no products